1. Acknowledgement

   Acknowledgments 03 January 2013 Pages: 1101 - 1104

2. Tomorrow’s World

   • I. Ralph Edwards

   Editorial 03 January 2013 Pages: 1105 - 1108

3. Cisplatin Overdose

   • Roger Y. Tsang
   • Turki Al-Fayea
   • Heather-Jane Au

   Practical Drug Safety 03 January 2013 Pages: 1109 - 1122

4. Benefit-Risk Assessment of Leflunomide

   • Nicola Alcorn
   • Sarah Saunders
   • Rajan Madhok

   Review Article 03 January 2013 Pages: 1123 - 1134

5. Improving Follow-Up Rates in Spontaneous Adverse Drug Reaction Reporting

   • Christopher Anton
   • Anthony R. Cox
   • Robin E. Ferner

   Short Communication 03 January 2013 Pages: 1135 - 1140

6. Safety and Quality Assessment of 175 Illegal Sexual Enhancement Products Seized in Red-Light Districts in Singapore

   • Min-Yong Low
   • Yun Zeng
   • Hwee-Ling Koh

   Short Communication 03 January 2013 Pages: 1141 - 1146

7. Messages about Black-Box Warnings

   • Pierre L. Yong
   • Cabral Bigman
   • Judith A. Long

   Original Research Article 03 January 2013 Pages: 1147 - 1157

8. The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive Disorder

   • Gerald Gartlehner
   • Kylie Thaler
   • Bradley N. Gaynes

   Original Research Article 03 January 2013 Pages: 1159 - 1173

9. Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approval

   • Thijs J. Giezen
   • Aukje K. Mantel-Teeuwisse
   • Hubert G. M. Leufkens

   Original Research Article 03 January 2013 Pages: 1175 - 1187

10. Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions

    • Arjen F. J. Geerts
    • Fred H. P. De Koning
    • Toine C. G. Egberts

    Original Research Article 03 January 2013 Pages: 1189 - 1197